You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Staying Abreast of the Latest Advances in Hereditary Angioedema: Emerging Therapies and Implications for Practice

  • Authors: Marcus Maurer, MD; Timothy Craig, DO; ​​​​​​Sorena Kiani, MBPhD, FRCP, FRCPath
  • CME / ABIM MOC Released: 3/30/2023
  • Valid for credit through: 3/30/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for allergists/clinical immunologists, pediatricians, and primary care physicians.

The goal of this activity is for learners to be better able to discuss the practice implications related to the latest developments in emerging therapies for HAE.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Unmet needs with currently approved prophylactic therapies for the management of HAE
    • Mechanism of action of novel long-term prophylaxis (LTP) emerging therapies for HAE
    • Latest clinical data with emerging LTP therapies


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Marcus Maurer, MD

    Professor of Dermatology and Allergy
    Executive Director, Institute of Allergology
    Charité – Universitätsmedizin Berlin
    Co-Director, Allergology and Immunology
    Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
    Berlin, Germany

    Disclosures

    Marcus Maurer, MD, has the following relevant financial relationships:
    Consultant or advisor for: Alnylam Pharmaceuticals, Inc; BioCryst Pharmaceuticals, Inc.; Centogene; CSL Behring; Dyax Corp.; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Shire; Takeda
    Speaker or member of speakers bureau for: Alnylam Pharmaceuticals, Inc; BioCryst Pharmaceuticals, Inc.; Centogene; CSL Behring; Dyax Corp.; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Shire; Takeda
    Research funding from: Alnylam Pharmaceuticals, Inc; BioCryst Pharmaceuticals, Inc.; Centogene; CSL Behring; Dyax Corp.; KalVista Pharmaceuticals; Pharming Group NV; Pharvaris; Shire; Takeda

  • Timothy Craig, DO

    Professor of Medicine and Pediatrics
    Division of Pulmonary, Allergy, and Critical Care Medicine
    Penn State Hershey Allergy, Asthma, and Immunology
    Penn State University
    Hershey, Pennsylvania, United States

    Disclosures

    Timothy Craig, DO, has the following relevant financial relationships:
    Consultant or advisor for: BioCryst Pharmaceuticals, Inc.; BioMarin Pharmaceutical Inc.; CSL Behring; Grifols; Regeneron Pharmaceuticals, Inc.; Takeda
    Speaker or member of speakers bureau for: CSL Behring; Grifols; Takeda
    Research funding from: BioCryst Pharmaceuticals, Inc.; BioMarin Pharmaceutical Inc.; CSL Behring; GlaxoSmithKline; Ionis Pharmaceuticals; Kalistor; Pharvaris; Regeneron Pharmaceuticals, Inc.; Takeda

  • ​​​​​​Sorena Kiani, MBPhD, FRCP, FRCPath

    Consultant Immunologist
    Royal Free NHS Foundation Trust
    London, United Kingdom

    Disclosures

    ​​​​​​Sorena Kiani, MBPhD, FRCP, FRCPath, has the following relevant financial relationships:
    Consultant or advisor for: Astria Therapeutics; BioCryst Pharmaceuticals, Inc.; CSL Behring; Takeda
    Speaker or member of speakers bureau for: BioCryst Pharmaceuticals, Inc.; CSL Behring; Takeda
    Contracted researcher for: BioCryst Pharmaceuticals, Inc.; KalVista Pharmaceuticals; Pharvaris; Takeda

Editor

  • Mihai Surducan​, ​PhD​

    Medical Education Director​, Medscape, LLC

    Disclosures

    ​​Mihai Surducan​, ​PhD​, has ​no relevant financial relationships.​​​

​​Compliance Reviewer

  • ​Stephanie Corder, ND, RN, CHCP

    ​​Associate Director, Accreditation and Compliance, Medscape, LLC​

    Disclosures

    ​Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Staying Abreast of the Latest Advances in Hereditary Angioedema: Emerging Therapies and Implications for Practice

Authors: Marcus Maurer, MD; Timothy Craig, DO; ​​​​​​Sorena Kiani, MBPhD, FRCP, FRCPathFaculty and Disclosures

CME / ABIM MOC Released: 3/30/2023

Valid for credit through: 3/30/2024

processing....

Educational Impact Challenge

The goal of this activity is for learners to be better able to discuss the practice implications related to the latest developments in emerging therapies for HAE.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print